Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Migraine Disorders | 48 | 2023 | 1620 | 8.080 |
Why?
|
Pain | 81 | 2022 | 4988 | 8.080 |
Why?
|
Analgesia | 15 | 2023 | 461 | 4.850 |
Why?
|
Brain | 93 | 2022 | 26388 | 4.440 |
Why?
|
Complex Regional Pain Syndromes | 11 | 2020 | 124 | 3.790 |
Why?
|
Nerve Net | 24 | 2020 | 2175 | 3.390 |
Why?
|
Neuralgia | 15 | 2022 | 570 | 3.230 |
Why?
|
Somatosensory Cortex | 14 | 2019 | 528 | 3.170 |
Why?
|
Pain Measurement | 43 | 2022 | 3420 | 3.100 |
Why?
|
Brain Mapping | 54 | 2022 | 6670 | 2.930 |
Why?
|
Magnetic Resonance Imaging | 101 | 2022 | 35425 | 2.570 |
Why?
|
Hot Temperature | 28 | 2017 | 1356 | 2.430 |
Why?
|
Reward | 11 | 2019 | 940 | 2.400 |
Why?
|
Analgesics | 17 | 2021 | 1040 | 2.290 |
Why?
|
Neural Pathways | 26 | 2021 | 2974 | 2.250 |
Why?
|
Hyperalgesia | 10 | 2023 | 502 | 1.990 |
Why?
|
Pain Threshold | 12 | 2021 | 584 | 1.710 |
Why?
|
Trigeminal Nerve | 10 | 2014 | 249 | 1.640 |
Why?
|
Pain Perception | 4 | 2020 | 191 | 1.500 |
Why?
|
Nociceptors | 8 | 2015 | 432 | 1.490 |
Why?
|
Pain, Intractable | 3 | 2023 | 130 | 1.400 |
Why?
|
Enkephalins | 12 | 1999 | 154 | 1.290 |
Why?
|
Eye Pain | 5 | 2021 | 47 | 1.280 |
Why?
|
Post-Traumatic Headache | 3 | 2021 | 74 | 1.280 |
Why?
|
Habenula | 3 | 2013 | 38 | 1.280 |
Why?
|
Cerebral Cortex | 19 | 2017 | 5709 | 1.260 |
Why?
|
Basal Ganglia | 5 | 2015 | 546 | 1.230 |
Why?
|
Sumatriptan | 2 | 2019 | 65 | 1.220 |
Why?
|
Reflex Sympathetic Dystrophy | 2 | 2019 | 58 | 1.170 |
Why?
|
Brain Stem | 9 | 2022 | 846 | 1.130 |
Why?
|
Photophobia | 7 | 2019 | 67 | 1.090 |
Why?
|
Physical Stimulation | 17 | 2017 | 525 | 1.070 |
Why?
|
Irritable Bowel Syndrome | 4 | 2019 | 445 | 1.070 |
Why?
|
Central Nervous System | 7 | 2010 | 1357 | 1.040 |
Why?
|
Amygdala | 8 | 2022 | 1315 | 1.030 |
Why?
|
Spectroscopy, Near-Infrared | 7 | 2021 | 721 | 1.030 |
Why?
|
Stress, Psychological | 10 | 2024 | 4245 | 0.990 |
Why?
|
Phantom Limb | 2 | 2023 | 91 | 0.970 |
Why?
|
Hypothalamus | 13 | 2017 | 1063 | 0.970 |
Why?
|
Protein Precursors | 12 | 1999 | 1154 | 0.960 |
Why?
|
Spinal Cord | 6 | 2020 | 1810 | 0.960 |
Why?
|
Humans | 232 | 2024 | 744366 | 0.960 |
Why?
|
Stress, Physiological | 8 | 2024 | 1403 | 0.920 |
Why?
|
Purine Nucleosides | 4 | 2004 | 30 | 0.890 |
Why?
|
Gyrus Cinguli | 5 | 2021 | 1091 | 0.880 |
Why?
|
Cerebellum | 7 | 2019 | 1488 | 0.860 |
Why?
|
Efferent Pathways | 3 | 2020 | 167 | 0.830 |
Why?
|
Solitary Nucleus | 1 | 2022 | 63 | 0.830 |
Why?
|
Placebo Effect | 2 | 2017 | 502 | 0.830 |
Why?
|
Behavior, Addictive | 4 | 2016 | 462 | 0.830 |
Why?
|
Thalamus | 9 | 2021 | 1023 | 0.820 |
Why?
|
Cornea | 7 | 2021 | 1524 | 0.810 |
Why?
|
Wakefulness | 4 | 2021 | 1245 | 0.810 |
Why?
|
Diffusion Tensor Imaging | 4 | 2021 | 2305 | 0.800 |
Why?
|
Allostasis | 2 | 2012 | 70 | 0.800 |
Why?
|
Dry Eye Syndromes | 3 | 2021 | 386 | 0.800 |
Why?
|
Awareness | 2 | 2018 | 640 | 0.790 |
Why?
|
Nucleus Accumbens | 4 | 2014 | 366 | 0.790 |
Why?
|
Buprenorphine | 5 | 2013 | 640 | 0.780 |
Why?
|
Oxyhemoglobins | 1 | 2022 | 216 | 0.780 |
Why?
|
Trigeminal Ganglion | 4 | 2009 | 186 | 0.780 |
Why?
|
Analgesics, Opioid | 13 | 2022 | 3677 | 0.770 |
Why?
|
Central Nervous System Diseases | 4 | 2014 | 518 | 0.760 |
Why?
|
Image Processing, Computer-Assisted | 25 | 2021 | 8949 | 0.750 |
Why?
|
Autonomic Nervous System | 3 | 2022 | 672 | 0.740 |
Why?
|
Placebos | 6 | 2017 | 1676 | 0.740 |
Why?
|
Rats, Sprague-Dawley | 25 | 2020 | 8300 | 0.730 |
Why?
|
Opioid-Related Disorders | 6 | 2022 | 2064 | 0.730 |
Why?
|
Receptors, Opioid | 2 | 2017 | 155 | 0.710 |
Why?
|
Male | 126 | 2022 | 350115 | 0.710 |
Why?
|
Central Nervous System Agents | 2 | 2013 | 72 | 0.700 |
Why?
|
Anesthesia, General | 3 | 2022 | 1171 | 0.690 |
Why?
|
Diagnostic Imaging | 7 | 2014 | 3508 | 0.690 |
Why?
|
Trigeminal Neuralgia | 3 | 2010 | 113 | 0.680 |
Why?
|
Peripheral Nerves | 2 | 2021 | 466 | 0.680 |
Why?
|
Naproxen | 1 | 2019 | 99 | 0.680 |
Why?
|
Neuronal Plasticity | 8 | 2018 | 1423 | 0.670 |
Why?
|
Stress Disorders, Post-Traumatic | 4 | 2022 | 4266 | 0.660 |
Why?
|
Corneal Diseases | 4 | 2016 | 636 | 0.650 |
Why?
|
Models, Neurological | 6 | 2019 | 1775 | 0.650 |
Why?
|
Ophthalmic Nerve | 2 | 2016 | 43 | 0.650 |
Why?
|
Hallucinogens | 1 | 2021 | 180 | 0.650 |
Why?
|
Sex Characteristics | 6 | 2019 | 2585 | 0.640 |
Why?
|
Thermosensing | 3 | 2020 | 56 | 0.630 |
Why?
|
Neurobiology | 2 | 2018 | 121 | 0.630 |
Why?
|
Emotions | 9 | 2021 | 2659 | 0.620 |
Why?
|
Animals | 78 | 2023 | 168768 | 0.620 |
Why?
|
Brain Concussion | 4 | 2021 | 1320 | 0.610 |
Why?
|
Rest | 7 | 2019 | 901 | 0.610 |
Why?
|
Pelvic Pain | 1 | 2019 | 274 | 0.610 |
Why?
|
Gambling | 2 | 2012 | 250 | 0.600 |
Why?
|
Cerebrum | 1 | 2018 | 137 | 0.600 |
Why?
|
Cold Temperature | 8 | 2013 | 772 | 0.590 |
Why?
|
Avoidance Learning | 1 | 2018 | 233 | 0.590 |
Why?
|
Prefrontal Cortex | 5 | 2019 | 2147 | 0.590 |
Why?
|
Trigeminal Nerve Diseases | 2 | 2008 | 55 | 0.580 |
Why?
|
Ketamine | 2 | 2015 | 501 | 0.580 |
Why?
|
Drug Design | 3 | 2011 | 1076 | 0.580 |
Why?
|
Pulvinar | 2 | 2019 | 22 | 0.570 |
Why?
|
Consciousness | 3 | 2018 | 572 | 0.560 |
Why?
|
Adult | 73 | 2022 | 214052 | 0.550 |
Why?
|
Paraventricular Hypothalamic Nucleus | 6 | 1999 | 113 | 0.550 |
Why?
|
Blood-Brain Barrier | 5 | 2020 | 1019 | 0.550 |
Why?
|
Drug Discovery | 3 | 2014 | 1058 | 0.540 |
Why?
|
Unconsciousness | 1 | 2018 | 263 | 0.540 |
Why?
|
Touch | 6 | 2010 | 306 | 0.540 |
Why?
|
Serotonin 5-HT1 Receptor Agonists | 1 | 2015 | 43 | 0.540 |
Why?
|
Cortical Spreading Depression | 2 | 2018 | 276 | 0.530 |
Why?
|
Touch Perception | 1 | 2017 | 114 | 0.530 |
Why?
|
Endometriosis | 2 | 2022 | 839 | 0.520 |
Why?
|
Peripheral Nervous System Diseases | 5 | 2019 | 685 | 0.520 |
Why?
|
Female | 85 | 2022 | 380193 | 0.520 |
Why?
|
Clinical Trials as Topic | 8 | 2016 | 7914 | 0.510 |
Why?
|
Glutamine | 2 | 2016 | 579 | 0.510 |
Why?
|
Narcotics | 3 | 2006 | 343 | 0.500 |
Why?
|
Adolescent | 36 | 2022 | 85779 | 0.500 |
Why?
|
Afferent Pathways | 4 | 2012 | 302 | 0.500 |
Why?
|
Neuropharmacology | 2 | 2011 | 21 | 0.500 |
Why?
|
Pain, Postoperative | 3 | 2019 | 1643 | 0.490 |
Why?
|
Light | 7 | 2022 | 1374 | 0.490 |
Why?
|
Hemodynamics | 4 | 2021 | 4196 | 0.490 |
Why?
|
Anatomy, Artistic | 1 | 2014 | 52 | 0.490 |
Why?
|
Drug Resistance | 2 | 2018 | 1608 | 0.480 |
Why?
|
Tibial Nerve | 2 | 2005 | 50 | 0.480 |
Why?
|
Cerebrovascular Circulation | 4 | 2019 | 2732 | 0.470 |
Why?
|
Rats | 26 | 2020 | 24252 | 0.470 |
Why?
|
Aspartic Acid | 1 | 2016 | 576 | 0.460 |
Why?
|
Young Adult | 28 | 2021 | 56429 | 0.460 |
Why?
|
Nalbuphine | 1 | 2013 | 20 | 0.450 |
Why?
|
Organ Specificity | 3 | 2019 | 2008 | 0.450 |
Why?
|
Headache | 4 | 2023 | 1226 | 0.440 |
Why?
|
Anesthetics | 2 | 2017 | 539 | 0.440 |
Why?
|
Locus Coeruleus | 1 | 2014 | 176 | 0.440 |
Why?
|
Demyelinating Diseases | 1 | 2015 | 354 | 0.440 |
Why?
|
Sciatic Neuropathy | 2 | 2005 | 74 | 0.430 |
Why?
|
Frontal Lobe | 3 | 2016 | 1406 | 0.420 |
Why?
|
Psychophysics | 6 | 2019 | 309 | 0.420 |
Why?
|
Hypesthesia | 2 | 2019 | 109 | 0.420 |
Why?
|
Erythromelalgia | 1 | 2012 | 15 | 0.420 |
Why?
|
Yohimbine | 1 | 2012 | 62 | 0.420 |
Why?
|
Adaptation, Psychological | 2 | 2014 | 2575 | 0.420 |
Why?
|
Neurotransmitter Agents | 5 | 2019 | 647 | 0.420 |
Why?
|
gamma-Aminobutyric Acid | 7 | 2019 | 1121 | 0.410 |
Why?
|
Pleasure | 1 | 2012 | 41 | 0.410 |
Why?
|
Visual Pathways | 3 | 2019 | 565 | 0.410 |
Why?
|
Drug Evaluation, Preclinical | 5 | 2014 | 1375 | 0.410 |
Why?
|
Tomography, Optical | 2 | 2009 | 126 | 0.410 |
Why?
|
Cerebellar Diseases | 1 | 2014 | 226 | 0.410 |
Why?
|
Oxygen | 12 | 2015 | 4189 | 0.410 |
Why?
|
Pons | 2 | 2012 | 245 | 0.400 |
Why?
|
Parent-Child Relations | 1 | 2016 | 747 | 0.400 |
Why?
|
Disease Models, Animal | 10 | 2019 | 18034 | 0.400 |
Why?
|
Attitude | 1 | 2016 | 776 | 0.400 |
Why?
|
Blepharospasm | 1 | 2011 | 30 | 0.400 |
Why?
|
Periaqueductal Gray | 1 | 2011 | 108 | 0.390 |
Why?
|
Child | 26 | 2023 | 77709 | 0.380 |
Why?
|
Adaptation, Physiological | 3 | 2012 | 1312 | 0.370 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2008 | 692 | 0.370 |
Why?
|
Basal Metabolism | 1 | 2011 | 168 | 0.370 |
Why?
|
Glutamic Acid | 1 | 2016 | 1169 | 0.370 |
Why?
|
Motor Activity | 1 | 2020 | 2715 | 0.370 |
Why?
|
Membrane Potentials | 1 | 2013 | 1137 | 0.360 |
Why?
|
Guidelines as Topic | 3 | 2011 | 1405 | 0.360 |
Why?
|
Trigeminal Caudal Nucleus | 1 | 2009 | 18 | 0.350 |
Why?
|
Excitatory Amino Acid Agents | 1 | 2009 | 23 | 0.350 |
Why?
|
Pain Insensitivity, Congenital | 1 | 2009 | 9 | 0.340 |
Why?
|
Motor Cortex | 4 | 2014 | 986 | 0.340 |
Why?
|
Affect | 3 | 2013 | 1475 | 0.340 |
Why?
|
Gene Expression Regulation | 13 | 1999 | 12073 | 0.340 |
Why?
|
Anesthetics, Dissociative | 1 | 2009 | 80 | 0.330 |
Why?
|
Medical Records | 1 | 2014 | 1413 | 0.330 |
Why?
|
beta-Galactosidase | 8 | 1999 | 574 | 0.330 |
Why?
|
Comorbidity | 2 | 2022 | 10388 | 0.320 |
Why?
|
Catastrophization | 4 | 2022 | 316 | 0.320 |
Why?
|
Naloxone | 3 | 2013 | 367 | 0.320 |
Why?
|
Middle Aged | 40 | 2021 | 213390 | 0.320 |
Why?
|
Mononeuropathies | 1 | 2008 | 14 | 0.320 |
Why?
|
Neurosciences | 1 | 2013 | 348 | 0.320 |
Why?
|
Case-Control Studies | 12 | 2019 | 21748 | 0.310 |
Why?
|
Triazines | 1 | 2010 | 315 | 0.310 |
Why?
|
Colonoscopy | 1 | 2016 | 1367 | 0.310 |
Why?
|
Mental Disorders | 3 | 2017 | 6598 | 0.310 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 4 | 1999 | 514 | 0.310 |
Why?
|
Optic Nerve | 1 | 2011 | 554 | 0.300 |
Why?
|
Interleukin-1 | 3 | 2000 | 1263 | 0.300 |
Why?
|
Comprehension | 1 | 2012 | 610 | 0.290 |
Why?
|
Tics | 1 | 2007 | 70 | 0.290 |
Why?
|
Cross-Over Studies | 5 | 2013 | 2029 | 0.290 |
Why?
|
Aging | 2 | 2017 | 8664 | 0.290 |
Why?
|
Drug Evaluation | 1 | 2008 | 647 | 0.290 |
Why?
|
Parents | 3 | 2018 | 3405 | 0.290 |
Why?
|
Cluster Headache | 1 | 2007 | 54 | 0.280 |
Why?
|
Trigeminal Nuclei | 1 | 2006 | 41 | 0.280 |
Why?
|
Brachial Plexus | 1 | 2008 | 163 | 0.270 |
Why?
|
Neurons, Afferent | 3 | 2010 | 506 | 0.270 |
Why?
|
Temporal Lobe | 4 | 2019 | 1670 | 0.270 |
Why?
|
Face | 3 | 2009 | 994 | 0.270 |
Why?
|
Capsaicin | 1 | 2007 | 232 | 0.270 |
Why?
|
Behavior | 3 | 2017 | 561 | 0.270 |
Why?
|
Social Behavior | 1 | 2012 | 1127 | 0.270 |
Why?
|
Neurons | 10 | 2017 | 9340 | 0.270 |
Why?
|
Brain Chemistry | 1 | 2009 | 982 | 0.260 |
Why?
|
Reaction Time | 3 | 2012 | 2098 | 0.260 |
Why?
|
Societies, Medical | 1 | 2017 | 3743 | 0.260 |
Why?
|
Motivation | 2 | 2016 | 1971 | 0.260 |
Why?
|
Putamen | 2 | 2020 | 291 | 0.260 |
Why?
|
Chronic Disease | 10 | 2021 | 9145 | 0.260 |
Why?
|
Capillary Permeability | 2 | 2019 | 798 | 0.250 |
Why?
|
Nerve Fibers | 2 | 2021 | 687 | 0.250 |
Why?
|
Injections, Intravenous | 4 | 2017 | 1420 | 0.250 |
Why?
|
Nervous System Diseases | 2 | 2022 | 1622 | 0.250 |
Why?
|
Pediatrics | 2 | 2023 | 3475 | 0.250 |
Why?
|
Tongue | 1 | 2007 | 406 | 0.240 |
Why?
|
Empathy | 1 | 2009 | 474 | 0.240 |
Why?
|
Substance-Related Disorders | 3 | 2016 | 4257 | 0.240 |
Why?
|
Receptors, Opioid, mu | 2 | 2017 | 182 | 0.240 |
Why?
|
Morphine | 3 | 2006 | 657 | 0.240 |
Why?
|
Cyclohexanecarboxylic Acids | 4 | 2014 | 141 | 0.230 |
Why?
|
Medulla Oblongata | 3 | 2022 | 243 | 0.230 |
Why?
|
Spin Labels | 2 | 2017 | 332 | 0.230 |
Why?
|
Movement | 2 | 2007 | 1471 | 0.230 |
Why?
|
Dopamine | 3 | 2023 | 1591 | 0.230 |
Why?
|
Lipopolysaccharides | 3 | 2000 | 2216 | 0.230 |
Why?
|
Amines | 4 | 2014 | 276 | 0.220 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2010 | 2737 | 0.220 |
Why?
|
Naltrexone | 3 | 2013 | 307 | 0.220 |
Why?
|
Endocannabinoids | 1 | 2023 | 116 | 0.220 |
Why?
|
Dura Mater | 2 | 2018 | 291 | 0.220 |
Why?
|
Polyneuropathies | 1 | 2004 | 137 | 0.220 |
Why?
|
Peroneal Nerve | 1 | 2002 | 74 | 0.210 |
Why?
|
Hand | 2 | 2008 | 884 | 0.210 |
Why?
|
Cognition Disorders | 1 | 2017 | 4043 | 0.210 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2009 | 1516 | 0.210 |
Why?
|
Technology, Pharmaceutical | 1 | 2002 | 84 | 0.210 |
Why?
|
Internet | 1 | 2014 | 3056 | 0.210 |
Why?
|
Drug Delivery Systems | 3 | 2020 | 2219 | 0.200 |
Why?
|
Pharmaceutical Preparations | 1 | 2010 | 1070 | 0.200 |
Why?
|
Evoked Potentials, Somatosensory | 2 | 2015 | 243 | 0.200 |
Why?
|
Neuroprotective Agents | 1 | 2008 | 941 | 0.200 |
Why?
|
Infusions, Intravenous | 3 | 2013 | 2274 | 0.200 |
Why?
|
Doxorubicin | 1 | 2008 | 2234 | 0.190 |
Why?
|
Analysis of Variance | 5 | 2016 | 6366 | 0.190 |
Why?
|
Cohort Studies | 9 | 2023 | 40559 | 0.190 |
Why?
|
Ganglia, Spinal | 1 | 2023 | 519 | 0.190 |
Why?
|
Sodium Chloride | 2 | 2017 | 625 | 0.190 |
Why?
|
Pituitary-Adrenal System | 1 | 2024 | 553 | 0.190 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2019 | 957 | 0.180 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2013 | 10943 | 0.180 |
Why?
|
Anticonvulsants | 1 | 2010 | 1916 | 0.180 |
Why?
|
Foot | 1 | 2004 | 527 | 0.180 |
Why?
|
Drug Monitoring | 2 | 2010 | 956 | 0.180 |
Why?
|
Headache Disorders | 1 | 2022 | 130 | 0.180 |
Why?
|
Infusions, Intraventricular | 1 | 2019 | 36 | 0.180 |
Why?
|
Temperature | 2 | 2021 | 2204 | 0.180 |
Why?
|
Hippocampus | 1 | 2012 | 3675 | 0.180 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2024 | 703 | 0.170 |
Why?
|
Motor Skills Disorders | 1 | 2020 | 90 | 0.170 |
Why?
|
Sleep Disorders, Circadian Rhythm | 1 | 2022 | 222 | 0.170 |
Why?
|
Arrhythmias, Cardiac | 2 | 2022 | 2269 | 0.170 |
Why?
|
Microbubbles | 1 | 2020 | 128 | 0.170 |
Why?
|
Age Factors | 4 | 2019 | 18373 | 0.170 |
Why?
|
Sensory Thresholds | 2 | 2019 | 391 | 0.170 |
Why?
|
Low Back Pain | 1 | 2008 | 956 | 0.170 |
Why?
|
Sprains and Strains | 1 | 2019 | 78 | 0.170 |
Why?
|
Illness Behavior | 1 | 2018 | 22 | 0.170 |
Why?
|
Double-Blind Method | 6 | 2023 | 12025 | 0.170 |
Why?
|
Anesthesia | 1 | 2010 | 1561 | 0.170 |
Why?
|
Benzodiazepines | 4 | 2013 | 1101 | 0.170 |
Why?
|
Brain Diseases | 1 | 2008 | 1563 | 0.170 |
Why?
|
Anxiety | 4 | 2021 | 4293 | 0.160 |
Why?
|
Habituation, Psychophysiologic | 1 | 1999 | 154 | 0.160 |
Why?
|
Buttocks | 1 | 1998 | 110 | 0.160 |
Why?
|
Electroretinography | 2 | 2019 | 509 | 0.160 |
Why?
|
Synaptic Transmission | 3 | 2017 | 1178 | 0.160 |
Why?
|
Quality Control | 2 | 2011 | 841 | 0.160 |
Why?
|
Psychiatry | 1 | 2011 | 1695 | 0.160 |
Why?
|
Discrimination Learning | 1 | 2020 | 280 | 0.160 |
Why?
|
Drug Utilization Review | 1 | 1999 | 245 | 0.160 |
Why?
|
Narcotic Antagonists | 4 | 2012 | 562 | 0.160 |
Why?
|
Dark Adaptation | 1 | 2019 | 219 | 0.160 |
Why?
|
Nitroglycerin | 1 | 2019 | 325 | 0.150 |
Why?
|
Pia Mater | 1 | 2018 | 88 | 0.150 |
Why?
|
Thalamic Nuclei | 2 | 2023 | 114 | 0.150 |
Why?
|
Parkinson Disease | 1 | 2011 | 2775 | 0.150 |
Why?
|
Color Perception | 1 | 2018 | 213 | 0.150 |
Why?
|
Evoked Potentials, Visual | 2 | 2019 | 427 | 0.150 |
Why?
|
Recombinant Fusion Proteins | 4 | 1998 | 3773 | 0.150 |
Why?
|
Post-Concussion Syndrome | 1 | 2019 | 219 | 0.140 |
Why?
|
Mice, Transgenic | 10 | 2018 | 9735 | 0.140 |
Why?
|
Triamcinolone | 1 | 1996 | 68 | 0.140 |
Why?
|
Calcitonin Gene-Related Peptide | 2 | 2016 | 306 | 0.140 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2020 | 780 | 0.140 |
Why?
|
Melatonin | 1 | 2022 | 721 | 0.140 |
Why?
|
Trigeminal Nucleus, Spinal | 2 | 2008 | 18 | 0.140 |
Why?
|
Treatment Outcome | 11 | 2023 | 63107 | 0.140 |
Why?
|
Positron-Emission Tomography | 4 | 2017 | 6234 | 0.140 |
Why?
|
Basal Ganglia Diseases | 1 | 2016 | 149 | 0.140 |
Why?
|
Biomedical Research | 2 | 2013 | 3309 | 0.130 |
Why?
|
Drug-Seeking Behavior | 1 | 2016 | 48 | 0.130 |
Why?
|
Depression | 4 | 2021 | 7759 | 0.130 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2008 | 3326 | 0.130 |
Why?
|
Facial Pain | 1 | 2016 | 127 | 0.130 |
Why?
|
Drug Combinations | 2 | 2019 | 1958 | 0.130 |
Why?
|
Parietal Lobe | 3 | 2014 | 838 | 0.130 |
Why?
|
Ankle Injuries | 1 | 2019 | 331 | 0.130 |
Why?
|
Drug Industry | 2 | 2011 | 746 | 0.130 |
Why?
|
Retinal Cone Photoreceptor Cells | 1 | 2016 | 177 | 0.130 |
Why?
|
Hypoglycemia | 1 | 2022 | 861 | 0.120 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2016 | 369 | 0.120 |
Why?
|
Vasodilator Agents | 1 | 2019 | 976 | 0.120 |
Why?
|
Fluoroscopy | 1 | 1998 | 924 | 0.120 |
Why?
|
Midazolam | 1 | 2016 | 270 | 0.120 |
Why?
|
Muscle, Skeletal | 2 | 2020 | 4925 | 0.120 |
Why?
|
Cross-Sectional Studies | 8 | 2023 | 25039 | 0.120 |
Why?
|
Lidocaine | 1 | 1997 | 544 | 0.120 |
Why?
|
Neurosecretory Systems | 1 | 1995 | 231 | 0.120 |
Why?
|
Neuropeptides | 2 | 2017 | 942 | 0.120 |
Why?
|
Pruritus | 1 | 1997 | 361 | 0.120 |
Why?
|
Biological Clocks | 1 | 2016 | 322 | 0.120 |
Why?
|
Genes, fos | 1 | 1994 | 183 | 0.120 |
Why?
|
Parahippocampal Gyrus | 1 | 2014 | 116 | 0.120 |
Why?
|
Interviews as Topic | 1 | 2021 | 2539 | 0.120 |
Why?
|
Tears | 1 | 2015 | 256 | 0.120 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1997 | 657 | 0.110 |
Why?
|
Electromyography | 1 | 1998 | 1379 | 0.110 |
Why?
|
Reproducibility of Results | 9 | 2015 | 19905 | 0.110 |
Why?
|
Photic Stimulation | 3 | 2019 | 2026 | 0.110 |
Why?
|
Genitalia, Male | 1 | 1992 | 84 | 0.110 |
Why?
|
Conflict of Interest | 1 | 2017 | 544 | 0.110 |
Why?
|
Adrenergic alpha-2 Receptor Antagonists | 1 | 2012 | 14 | 0.110 |
Why?
|
Supraoptic Nucleus | 3 | 1999 | 28 | 0.110 |
Why?
|
Genes, Synthetic | 1 | 1992 | 90 | 0.110 |
Why?
|
Physicians | 2 | 2023 | 4567 | 0.100 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1782 | 0.100 |
Why?
|
Neurologic Examination | 1 | 2015 | 931 | 0.100 |
Why?
|
Administration, Sublingual | 1 | 2011 | 56 | 0.100 |
Why?
|
Nerve Block | 1 | 1998 | 644 | 0.100 |
Why?
|
Brain Waves | 1 | 2016 | 401 | 0.100 |
Why?
|
Body Weights and Measures | 1 | 2012 | 211 | 0.100 |
Why?
|
Normal Distribution | 2 | 2010 | 280 | 0.100 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2013 | 323 | 0.100 |
Why?
|
Appetite Depressants | 1 | 2012 | 110 | 0.100 |
Why?
|
Receptors, Neurokinin-1 | 1 | 2012 | 129 | 0.100 |
Why?
|
Health Care Surveys | 1 | 1999 | 2453 | 0.100 |
Why?
|
Sensation | 3 | 2019 | 336 | 0.100 |
Why?
|
Genitalia, Female | 1 | 1992 | 146 | 0.100 |
Why?
|
Conscious Sedation | 1 | 2016 | 528 | 0.100 |
Why?
|
Disease Progression | 3 | 2024 | 13286 | 0.100 |
Why?
|
Adolescent Behavior | 1 | 2020 | 1151 | 0.100 |
Why?
|
Genetic Markers | 1 | 2017 | 2634 | 0.100 |
Why?
|
Retina | 2 | 2019 | 2616 | 0.100 |
Why?
|
Visual Cortex | 1 | 2019 | 1149 | 0.090 |
Why?
|
Saline Solution, Hypertonic | 3 | 1998 | 110 | 0.090 |
Why?
|
Homeostasis | 1 | 2022 | 3339 | 0.090 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2013 | 629 | 0.090 |
Why?
|
Alzheimer Disease | 1 | 2011 | 8038 | 0.090 |
Why?
|
Forelimb | 1 | 2010 | 122 | 0.090 |
Why?
|
Phenotype | 3 | 2021 | 16367 | 0.090 |
Why?
|
Bipolar Disorder | 3 | 2011 | 5027 | 0.090 |
Why?
|
Biomarkers, Pharmacological | 1 | 2011 | 162 | 0.090 |
Why?
|
Early Diagnosis | 1 | 2015 | 1184 | 0.090 |
Why?
|
Time Factors | 6 | 2013 | 40075 | 0.090 |
Why?
|
Organ Size | 1 | 2015 | 2251 | 0.090 |
Why?
|
Caudate Nucleus | 1 | 2011 | 393 | 0.090 |
Why?
|
Spinal Cord Injuries | 1 | 2018 | 931 | 0.090 |
Why?
|
Interleukin-6 | 1 | 2000 | 3203 | 0.090 |
Why?
|
Trans-Activators | 1 | 2000 | 2926 | 0.090 |
Why?
|
Patient Compliance | 1 | 2000 | 2684 | 0.090 |
Why?
|
Sex Factors | 2 | 2014 | 10400 | 0.090 |
Why?
|
Aged | 12 | 2020 | 163288 | 0.090 |
Why?
|
Anticipation, Psychological | 1 | 2010 | 87 | 0.090 |
Why?
|
Species Specificity | 2 | 2013 | 2478 | 0.090 |
Why?
|
Models, Biological | 3 | 2014 | 9584 | 0.090 |
Why?
|
Self Report | 2 | 2020 | 3553 | 0.090 |
Why?
|
Abdominal Pain | 1 | 2016 | 1064 | 0.090 |
Why?
|
Statistics as Topic | 2 | 2015 | 2373 | 0.090 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2013 | 841 | 0.090 |
Why?
|
Microelectrodes | 1 | 2010 | 303 | 0.080 |
Why?
|
Disabled Persons | 2 | 2017 | 1212 | 0.080 |
Why?
|
Channelopathies | 1 | 2009 | 32 | 0.080 |
Why?
|
Microscopy, Confocal | 1 | 2015 | 1970 | 0.080 |
Why?
|
Psychotherapy | 2 | 2017 | 1642 | 0.080 |
Why?
|
Muscimol | 2 | 1999 | 69 | 0.080 |
Why?
|
Sleep | 4 | 2023 | 4622 | 0.080 |
Why?
|
Pilot Projects | 4 | 2022 | 8319 | 0.080 |
Why?
|
Circadian Rhythm | 3 | 2022 | 2624 | 0.080 |
Why?
|
Radionuclide Imaging | 1 | 2012 | 2031 | 0.080 |
Why?
|
Mice | 14 | 2023 | 81201 | 0.080 |
Why?
|
Models, Genetic | 2 | 1996 | 3493 | 0.080 |
Why?
|
Postoperative Complications | 2 | 2010 | 15297 | 0.080 |
Why?
|
Weight Gain | 2 | 2012 | 2293 | 0.080 |
Why?
|
Antipsychotic Agents | 3 | 2013 | 3057 | 0.080 |
Why?
|
Action Potentials | 2 | 2010 | 1806 | 0.080 |
Why?
|
Linear Models | 3 | 2010 | 5953 | 0.080 |
Why?
|
Cerebellar Nuclei | 1 | 2008 | 52 | 0.080 |
Why?
|
Reference Values | 2 | 2008 | 4982 | 0.080 |
Why?
|
Echo-Planar Imaging | 1 | 2012 | 659 | 0.080 |
Why?
|
Hypnotics and Sedatives | 1 | 2016 | 1162 | 0.080 |
Why?
|
Recovery of Function | 1 | 2018 | 2926 | 0.080 |
Why?
|
Dreams | 1 | 2009 | 147 | 0.080 |
Why?
|
Meta-Analysis as Topic | 1 | 2012 | 1342 | 0.080 |
Why?
|
Epilepsy | 1 | 2023 | 3310 | 0.070 |
Why?
|
Glucocorticoids | 1 | 1996 | 2108 | 0.070 |
Why?
|
Dipeptides | 1 | 2009 | 409 | 0.070 |
Why?
|
Sympathetic Nervous System | 2 | 2022 | 513 | 0.070 |
Why?
|
Military Personnel | 1 | 2016 | 1133 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2460 | 0.070 |
Why?
|
Estrogens | 1 | 2014 | 1566 | 0.070 |
Why?
|
Dendritic Cells | 1 | 2018 | 2725 | 0.070 |
Why?
|
Injections, Intraperitoneal | 2 | 2012 | 425 | 0.070 |
Why?
|
Socioeconomic Factors | 2 | 2018 | 7785 | 0.070 |
Why?
|
Perception | 1 | 2013 | 1198 | 0.070 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9274 | 0.070 |
Why?
|
Limbic System | 1 | 2009 | 426 | 0.070 |
Why?
|
Severity of Illness Index | 2 | 2017 | 15535 | 0.070 |
Why?
|
Models, Economic | 1 | 2010 | 712 | 0.070 |
Why?
|
Research | 1 | 2014 | 1999 | 0.070 |
Why?
|
Anti-Bacterial Agents | 1 | 2004 | 7182 | 0.070 |
Why?
|
Inflammation | 3 | 2012 | 10637 | 0.070 |
Why?
|
Lower Extremity | 1 | 2013 | 1158 | 0.070 |
Why?
|
Sensory Receptor Cells | 1 | 2010 | 493 | 0.070 |
Why?
|
Imipramine | 1 | 2005 | 97 | 0.070 |
Why?
|
Physician-Patient Relations | 2 | 2014 | 3229 | 0.070 |
Why?
|
Postoperative Period | 1 | 2010 | 1842 | 0.060 |
Why?
|
Prospective Studies | 4 | 2023 | 53290 | 0.060 |
Why?
|
Individuality | 1 | 2007 | 307 | 0.060 |
Why?
|
Electric Stimulation | 2 | 2019 | 1767 | 0.060 |
Why?
|
Cyclic AMP | 2 | 1999 | 1472 | 0.060 |
Why?
|
Administration, Topical | 1 | 2007 | 690 | 0.060 |
Why?
|
Cognition | 2 | 2015 | 6770 | 0.060 |
Why?
|
DNA-Binding Proteins | 2 | 2000 | 9647 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2017 | 3611 | 0.060 |
Why?
|
Injections | 1 | 2008 | 840 | 0.060 |
Why?
|
Transcription, Genetic | 1 | 1999 | 7721 | 0.060 |
Why?
|
Injections, Intramuscular | 2 | 2012 | 552 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 2 | 2023 | 20130 | 0.060 |
Why?
|
Eating | 2 | 2014 | 1536 | 0.060 |
Why?
|
Energy Intake | 1 | 2012 | 2148 | 0.060 |
Why?
|
Receptors, GABA-A | 2 | 1986 | 627 | 0.060 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2011 | 1953 | 0.060 |
Why?
|
Child, Preschool | 2 | 2017 | 41005 | 0.060 |
Why?
|
Raynaud Disease | 1 | 2004 | 75 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2400 | 0.060 |
Why?
|
Skin | 1 | 2017 | 4372 | 0.060 |
Why?
|
Drug Prescriptions | 1 | 2013 | 1637 | 0.060 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2005 | 434 | 0.060 |
Why?
|
Phosphorylation | 4 | 1999 | 8436 | 0.060 |
Why?
|
Macrophages | 1 | 2018 | 5660 | 0.060 |
Why?
|
Fear | 2 | 2015 | 1440 | 0.050 |
Why?
|
Catheter Ablation | 1 | 2016 | 2758 | 0.050 |
Why?
|
Fourier Analysis | 1 | 2004 | 447 | 0.050 |
Why?
|
Life Style | 1 | 2014 | 3835 | 0.050 |
Why?
|
Suicide | 1 | 2013 | 1474 | 0.050 |
Why?
|
Receptor, Cannabinoid, CB1 | 1 | 2023 | 143 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2019 | 77460 | 0.050 |
Why?
|
Posterior Horn Cells | 1 | 2002 | 87 | 0.050 |
Why?
|
Pyrogens | 2 | 1978 | 17 | 0.050 |
Why?
|
Brain Injuries | 1 | 2014 | 2029 | 0.050 |
Why?
|
Age of Onset | 1 | 2008 | 3270 | 0.050 |
Why?
|
Adipose Tissue | 1 | 2013 | 3280 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-fos | 2 | 1994 | 575 | 0.050 |
Why?
|
Schizophrenia | 2 | 2013 | 6882 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2716 | 0.050 |
Why?
|
Neuropsychological Tests | 1 | 2014 | 6994 | 0.050 |
Why?
|
Serotonin | 2 | 2014 | 1017 | 0.050 |
Why?
|
Baroreflex | 1 | 2022 | 146 | 0.050 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2002 | 377 | 0.050 |
Why?
|
Forecasting | 1 | 2010 | 2951 | 0.050 |
Why?
|
Solubility | 1 | 2002 | 1088 | 0.050 |
Why?
|
Freund's Adjuvant | 1 | 2000 | 139 | 0.050 |
Why?
|
Electronics, Medical | 1 | 2000 | 71 | 0.050 |
Why?
|
Ethics | 1 | 2000 | 94 | 0.050 |
Why?
|
Thumb | 1 | 2002 | 227 | 0.050 |
Why?
|
Prosencephalon | 1 | 2002 | 303 | 0.050 |
Why?
|
Spinal Nerves | 1 | 2000 | 86 | 0.050 |
Why?
|
Toxicology | 1 | 2000 | 106 | 0.040 |
Why?
|
United States | 4 | 2020 | 69872 | 0.040 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2010 | 6036 | 0.040 |
Why?
|
Cells, Cultured | 4 | 1999 | 19233 | 0.040 |
Why?
|
1-Methyl-3-isobutylxanthine | 1 | 1999 | 102 | 0.040 |
Why?
|
Rod Opsins | 1 | 2019 | 111 | 0.040 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 1999 | 222 | 0.040 |
Why?
|
Phosphoserine | 1 | 1999 | 206 | 0.040 |
Why?
|
In Situ Hybridization | 2 | 1994 | 1950 | 0.040 |
Why?
|
Drug Administration Routes | 1 | 1999 | 153 | 0.040 |
Why?
|
Injections, Intraventricular | 1 | 1999 | 231 | 0.040 |
Why?
|
STAT1 Transcription Factor | 1 | 2000 | 320 | 0.040 |
Why?
|
Cyclic AMP Response Element Modulator | 1 | 1999 | 87 | 0.040 |
Why?
|
Hindlimb | 1 | 2000 | 504 | 0.040 |
Why?
|
Aminooxyacetic Acid | 1 | 1998 | 7 | 0.040 |
Why?
|
Serologic Tests | 1 | 2000 | 374 | 0.040 |
Why?
|
Sacroiliac Joint | 1 | 1998 | 62 | 0.040 |
Why?
|
Cost-Benefit Analysis | 1 | 2011 | 5388 | 0.040 |
Why?
|
Urinalysis | 1 | 2000 | 369 | 0.040 |
Why?
|
Iopamidol | 1 | 1998 | 191 | 0.040 |
Why?
|
Decision Making | 1 | 2012 | 3888 | 0.040 |
Why?
|
Sciatica | 1 | 1998 | 98 | 0.040 |
Why?
|
Logistic Models | 2 | 2017 | 13409 | 0.040 |
Why?
|
Work Schedule Tolerance | 1 | 2022 | 563 | 0.040 |
Why?
|
GABA-A Receptor Agonists | 1 | 1998 | 84 | 0.040 |
Why?
|
Algorithms | 4 | 2011 | 13882 | 0.040 |
Why?
|
Skin Temperature | 2 | 1993 | 93 | 0.040 |
Why?
|
Patient Acceptance of Health Care | 1 | 2011 | 3020 | 0.040 |
Why?
|
Hair | 1 | 2000 | 481 | 0.040 |
Why?
|
Treatment Refusal | 1 | 2000 | 421 | 0.040 |
Why?
|
Education | 1 | 2020 | 543 | 0.040 |
Why?
|
Celiac Plexus | 1 | 1996 | 26 | 0.040 |
Why?
|
Hand Strength | 1 | 2020 | 448 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17446 | 0.040 |
Why?
|
Cryptosporidiosis | 1 | 1997 | 60 | 0.040 |
Why?
|
Vibration | 1 | 2019 | 326 | 0.040 |
Why?
|
Secondary Prevention | 1 | 2003 | 1530 | 0.040 |
Why?
|
Single-Blind Method | 1 | 2000 | 1590 | 0.040 |
Why?
|
Models, Theoretical | 1 | 2009 | 3589 | 0.040 |
Why?
|
Sacrum | 1 | 1998 | 288 | 0.040 |
Why?
|
Radiography | 1 | 2008 | 7023 | 0.040 |
Why?
|
src-Family Kinases | 1 | 1999 | 551 | 0.040 |
Why?
|
TRPV Cation Channels | 1 | 2018 | 237 | 0.040 |
Why?
|
Motor Neurons | 2 | 1998 | 844 | 0.030 |
Why?
|
Occupational Therapy | 1 | 2017 | 134 | 0.030 |
Why?
|
Saliva | 1 | 2000 | 809 | 0.030 |
Why?
|
Rare Diseases | 1 | 2021 | 553 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2282 | 0.030 |
Why?
|
Color | 1 | 2017 | 307 | 0.030 |
Why?
|
Water | 1 | 2002 | 1395 | 0.030 |
Why?
|
Quality of Life | 2 | 2017 | 12802 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2001 | 2887 | 0.030 |
Why?
|
Body Temperature Regulation | 1 | 1977 | 252 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2000 | 874 | 0.030 |
Why?
|
Needles | 1 | 1998 | 449 | 0.030 |
Why?
|
Biological Transport | 1 | 2020 | 2120 | 0.030 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2008 | 2020 | 0.030 |
Why?
|
Organ Culture Techniques | 1 | 1998 | 813 | 0.030 |
Why?
|
Risk Factors | 3 | 2019 | 72296 | 0.030 |
Why?
|
Software | 1 | 2009 | 4441 | 0.030 |
Why?
|
Disabled Children | 1 | 2018 | 247 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2000 | 738 | 0.030 |
Why?
|
Body Temperature | 1 | 1978 | 777 | 0.030 |
Why?
|
Signal Transduction | 2 | 2013 | 23404 | 0.030 |
Why?
|
Radiology, Interventional | 1 | 1998 | 460 | 0.030 |
Why?
|
Acetabulum | 1 | 1998 | 525 | 0.030 |
Why?
|
Methadone | 1 | 1997 | 306 | 0.030 |
Why?
|
Anxiety Disorders | 1 | 2006 | 2690 | 0.030 |
Why?
|
Microdialysis | 1 | 2014 | 158 | 0.030 |
Why?
|
Retinal Ganglion Cells | 1 | 2019 | 770 | 0.030 |
Why?
|
Osmotic Pressure | 1 | 1994 | 151 | 0.030 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2022 | 2016 | 0.030 |
Why?
|
Hypothalamic Hormones | 1 | 2014 | 147 | 0.030 |
Why?
|
Pituitary Hormones | 1 | 2014 | 183 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 1994 | 286 | 0.030 |
Why?
|
Incidence | 2 | 2023 | 20952 | 0.030 |
Why?
|
Movement Disorders | 1 | 2016 | 446 | 0.030 |
Why?
|
Glutamates | 1 | 2014 | 398 | 0.030 |
Why?
|
RNA, Messenger | 3 | 1999 | 13035 | 0.030 |
Why?
|
Depressive Disorder, Major | 1 | 2011 | 4639 | 0.030 |
Why?
|
Depressive Disorder | 1 | 2006 | 3747 | 0.030 |
Why?
|
Vasopressins | 1 | 2014 | 370 | 0.030 |
Why?
|
Hypothalamus, Middle | 2 | 1997 | 25 | 0.030 |
Why?
|
Histamine | 1 | 2014 | 507 | 0.030 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2022 | 1433 | 0.030 |
Why?
|
Melanins | 1 | 2014 | 289 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2000 | 4933 | 0.030 |
Why?
|
Blood Volume | 1 | 1994 | 565 | 0.030 |
Why?
|
Genes, jun | 1 | 1992 | 71 | 0.030 |
Why?
|
Femur | 1 | 1998 | 1297 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2013 | 528 | 0.030 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2010 | 1534 | 0.030 |
Why?
|
Appetite Regulation | 1 | 2012 | 88 | 0.030 |
Why?
|
Behavior Therapy | 1 | 2017 | 865 | 0.030 |
Why?
|
Norepinephrine | 1 | 2014 | 909 | 0.030 |
Why?
|
Prognosis | 1 | 2012 | 29060 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2019 | 20824 | 0.020 |
Why?
|
Radiography, Interventional | 1 | 1998 | 1095 | 0.020 |
Why?
|
Mood Disorders | 1 | 2017 | 1106 | 0.020 |
Why?
|
Kinetics | 1 | 1999 | 6476 | 0.020 |
Why?
|
Peritoneal Neoplasms | 1 | 1997 | 665 | 0.020 |
Why?
|
Heart Rate | 1 | 2022 | 4092 | 0.020 |
Why?
|
Oligonucleotides | 1 | 1994 | 572 | 0.020 |
Why?
|
Oxytocin | 1 | 2014 | 394 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1994 | 794 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 1996 | 4320 | 0.020 |
Why?
|
Up-Regulation | 1 | 1999 | 4222 | 0.020 |
Why?
|
Tissue Distribution | 1 | 1994 | 2327 | 0.020 |
Why?
|
Pancreatitis | 1 | 1996 | 1092 | 0.020 |
Why?
|
Estradiol | 1 | 1997 | 2020 | 0.020 |
Why?
|
Fever | 1 | 1977 | 1616 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2015 | 2971 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2023 | 3841 | 0.020 |
Why?
|
Hypertension | 1 | 2009 | 8479 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1999 | 6621 | 0.020 |
Why?
|
Euphoria | 1 | 2008 | 67 | 0.020 |
Why?
|
Delayed-Action Preparations | 1 | 2012 | 968 | 0.020 |
Why?
|
Drug Synergism | 1 | 2013 | 1794 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2011 | 940 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2012 | 1892 | 0.020 |
Why?
|
Axons | 1 | 1996 | 1685 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2015 | 1828 | 0.020 |
Why?
|
Arteries | 1 | 2013 | 1119 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2017 | 57776 | 0.020 |
Why?
|
Repressor Proteins | 1 | 1999 | 3024 | 0.020 |
Why?
|
Random Allocation | 1 | 2012 | 2428 | 0.020 |
Why?
|
Protein Binding | 1 | 2000 | 9384 | 0.020 |
Why?
|
Drug Interactions | 1 | 2012 | 1460 | 0.020 |
Why?
|
Stomach Neoplasms | 1 | 1997 | 1332 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2018 | 21833 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9312 | 0.020 |
Why?
|
Escherichia coli | 1 | 1999 | 4217 | 0.020 |
Why?
|
4-Aminobutyrate Transaminase | 1 | 1986 | 13 | 0.020 |
Why?
|
Blood Pressure | 1 | 2022 | 8551 | 0.020 |
Why?
|
Glutamate Dehydrogenase | 1 | 1986 | 52 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2000 | 11366 | 0.020 |
Why?
|
Computer Simulation | 2 | 2010 | 6194 | 0.020 |
Why?
|
Flunitrazepam | 1 | 1985 | 20 | 0.020 |
Why?
|
Aldehyde Oxidoreductases | 1 | 1986 | 88 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2009 | 1005 | 0.020 |
Why?
|
Peroxides | 1 | 2005 | 74 | 0.020 |
Why?
|
Synaptic Membranes | 1 | 1985 | 91 | 0.020 |
Why?
|
Enzyme Induction | 1 | 1986 | 475 | 0.020 |
Why?
|
Succinate-Semialdehyde Dehydrogenase | 1 | 1986 | 70 | 0.020 |
Why?
|
Contrast Media | 1 | 1998 | 5300 | 0.020 |
Why?
|
Base Sequence | 2 | 1994 | 12797 | 0.020 |
Why?
|
Suprachiasmatic Nucleus | 1 | 1986 | 148 | 0.020 |
Why?
|
Carbamazepine | 1 | 1986 | 229 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2017 | 39052 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2000 | 14561 | 0.020 |
Why?
|
Functional Laterality | 2 | 2005 | 2290 | 0.020 |
Why?
|
Behavior, Animal | 1 | 2012 | 1881 | 0.010 |
Why?
|
Leptin | 1 | 2012 | 1600 | 0.010 |
Why?
|
Attention | 1 | 2014 | 2397 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1985 | 2186 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2916 | 0.010 |
Why?
|
Acetylcholine | 1 | 1986 | 621 | 0.010 |
Why?
|
Zollinger-Ellison Syndrome | 1 | 1983 | 15 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 1994 | 18111 | 0.010 |
Why?
|
Urea | 1 | 2005 | 450 | 0.010 |
Why?
|
Pyloric Antrum | 1 | 1983 | 69 | 0.010 |
Why?
|
Valproic Acid | 1 | 1986 | 445 | 0.010 |
Why?
|
Stomach Ulcer | 1 | 1983 | 125 | 0.010 |
Why?
|
Lithium | 1 | 1986 | 601 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 13991 | 0.010 |
Why?
|
Clozapine | 1 | 2006 | 498 | 0.010 |
Why?
|
Lipids | 1 | 2013 | 3307 | 0.010 |
Why?
|
Gene Expression | 1 | 1995 | 7798 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 1999 | 7282 | 0.010 |
Why?
|
Palliative Care | 1 | 1997 | 3493 | 0.010 |
Why?
|
Rabbits | 2 | 1978 | 4894 | 0.010 |
Why?
|
Bayes Theorem | 1 | 2009 | 2307 | 0.010 |
Why?
|
Risk Assessment | 2 | 2015 | 23336 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14723 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2013 | 3864 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2012 | 3188 | 0.010 |
Why?
|
Quinones | 1 | 1999 | 76 | 0.010 |
Why?
|
Rifabutin | 1 | 1999 | 52 | 0.010 |
Why?
|
Benzoquinones | 1 | 1999 | 201 | 0.010 |
Why?
|
Psychotic Disorders | 1 | 2013 | 3046 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2005 | 2715 | 0.010 |
Why?
|
Gastrectomy | 1 | 1983 | 663 | 0.010 |
Why?
|
Fenclonine | 1 | 1977 | 16 | 0.010 |
Why?
|
Lactams, Macrocyclic | 1 | 1999 | 320 | 0.010 |
Why?
|
Genetic Variation | 1 | 2013 | 6542 | 0.010 |
Why?
|
Prostaglandins E | 1 | 1977 | 172 | 0.010 |
Why?
|
Spinothalamic Tracts | 1 | 1996 | 8 | 0.010 |
Why?
|
Hydromorphone | 1 | 1997 | 65 | 0.010 |
Why?
|
Papio | 1 | 1978 | 656 | 0.010 |
Why?
|
Promoter Regions, Genetic | 2 | 1999 | 5867 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2013 | 9955 | 0.010 |
Why?
|
Body Mass Index | 1 | 2013 | 12721 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13693 | 0.010 |
Why?
|
Retreatment | 1 | 1997 | 610 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2006 | 2897 | 0.010 |
Why?
|
Ovariectomy | 1 | 1997 | 661 | 0.010 |
Why?
|
Thermoreceptors | 1 | 1993 | 27 | 0.010 |
Why?
|
Animals, Newborn | 1 | 1999 | 2726 | 0.010 |
Why?
|
Infant | 1 | 2015 | 35134 | 0.010 |
Why?
|
Enhancer Elements, Genetic | 1 | 1999 | 1340 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2008 | 15078 | 0.010 |
Why?
|
Cell Count | 1 | 1996 | 1856 | 0.010 |
Why?
|
Cattle | 1 | 1978 | 3922 | 0.010 |
Why?
|
Astrocytes | 1 | 1999 | 1273 | 0.010 |
Why?
|
Transfection | 1 | 1999 | 5895 | 0.010 |
Why?
|
Pregnancy | 1 | 1992 | 29144 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 1993 | 1799 | 0.010 |
Why?
|
Leukocytes | 1 | 1978 | 2045 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 1999 | 3799 | 0.000 |
Why?
|
Swine | 1 | 1978 | 5918 | 0.000 |
Why?
|
Recurrence | 1 | 1983 | 8340 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1983 | 12961 | 0.000 |
Why?
|